Loading...
Macrocyclic and peptidomimetic compounds as broad-spectrum antivirals against 3C or 3C-like proteases of picornaviruses, caliciviruses and coronaviruses
Chang, Kyeong-Ok Kim, Yunjeong Groutas, William C.
Chang, Kyeong-Ok
Kim, Yunjeong
Groutas, William C.
Files
Loading...
U.S. 20150133368 A1
Adobe PDF, 1.69 MB
Location
Time Period
Advisors
Original Date
Digitization Date
Issue Date
2015-05-14
Type
Patent
Genre
Keywords
Subjects (LCSH)
Citation
Chang, Kyeong-Ok; Kim, Yunjeong; Groutas, William C., inventors. Kansas State University Research Foundation (Manhattan, KS), Wichita State University (Wichita, KS), assignees. Macrocyclic and Peptidomimetic Compounds as Broad-Spectrum Antivirals Against 3C or 3C-Like Proteases of Picornaviruses, Caliciviruses and Coronaviruses. United States patent US 20150133368 A1. 2015, May 14.
Abstract
Antiviral protease inhibitors, including macrocylic transition state inhibitors and peptidomimetics are disclosed, along with related antiviral compounds, and methods of using the same to treat or prevent viral infection and disease. The compounds possess broad-spectrum activity against viruses that belong to the picornavirus-like supercluster, which include important human and animal pathogens including noroviruses, sapoviruses, enteroviruses, poliovirus, foot-and-mouth disease virus, hepatitis A virus, human rhinovirus (cause of common cold), human coronavirus (another cause of common cold), transmissible gastroenteritis virus, murine hepatitis virus, feline infectious peritonitis virus, and severe acute respiratory syndrome coronavirus.
Table of Contents
Description
WSU inventor: William C. Groutas, Dept. of Chemistry, College of Liberal Arts and Sciences
Application No: 14/398290 filed May 2, 2013. Patent No: US 20150133368 A1 granted May 14, 2015
Application No: 14/398290 filed May 2, 2013. Patent No: US 20150133368 A1 granted May 14, 2015
Publisher
United States Patent and Trademark Office
Journal
Book Title
Series
Digital Collection
Finding Aid URL
Use and Reproduction
Status: Expired, Fee Related; Anticipated expiration: 2032-09-27